These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15037498)

  • 1. Differentiating inhalational anthrax from other influenza-like illnesses in the setting of a national or regional anthrax outbreak.
    Cinti SK; Saravolatz L; Nafziger D; Sunstrum J; Blackburn G
    Arch Intern Med; 2004 Mar; 164(6):674-6. PubMed ID: 15037498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for distinguishing influenza-like illness from inhalational anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):984-6. PubMed ID: 11724153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing influenza-like illness from inhalational anthrax.
    Lovell RD
    ED Manag; 2002 Jan; 14(1):suppl 2. PubMed ID: 11883060
    [No Abstract]   [Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Considerations for distinguishing influenza-like illness from inhalational anthrax.
    JAMA; 2001 Nov; 286(20):2537-9. PubMed ID: 11763847
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical predictors of bioterrorism-related inhalational anthrax.
    Kyriacou DN; Stein AC; Yarnold PR; Courtney DM; Nelson RR; Noskin GA; Handler JA; Frerichs RR
    Lancet; 2004 Jul 31-Aug 6; 364(9432):449-52. PubMed ID: 15288744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased detection of rickettsialpox in a New York City hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism.
    Koss T; Carter EL; Grossman ME; Silvers DN; Rabinowitz AD; Singleton J; Zaki SR; Paddock CD
    Arch Dermatol; 2003 Dec; 139(12):1545-52. PubMed ID: 14676069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza review and outlook. 2002-2003, with additional considerations for differentiation from inhalation anthrax.
    Morgan R; Tan C; O'Donnell C; Bresnitz E
    N J Med; 2002 Oct; 99(10):21-6; quiz 26-8. PubMed ID: 12400233
    [No Abstract]   [Full Text] [Related]  

  • 8. Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses.
    Fine AM; Wong JB; Fraser HS; Fleisher GR; Mandl KD
    Ann Emerg Med; 2004 Mar; 43(3):318-28. PubMed ID: 14985657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza-like illness: a monitoring system.
    Knox JD; Anderson RA
    Ecol Dis; 1982; 1(1):87-91. PubMed ID: 6926841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical signs differ between inhalational anthrax, influenza.
    Am J Health Syst Pharm; 2001 Dec; 58(24):2354. PubMed ID: 11794945
    [No Abstract]   [Full Text] [Related]  

  • 11. Best defense against bioterrorism.
    Johns Hopkins Med Lett Health After 50; 2002 Feb; 13(12):1-2. PubMed ID: 12619622
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses.
    Kuehnert MJ; Doyle TJ; Hill HA; Bridges CB; Jernigan JA; Dull PM; Reissman DB; Ashford DA; Jernigan DB
    Clin Infect Dis; 2003 Feb; 36(3):328-36. PubMed ID: 12539075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid assessment of agents of biological terrorism: defining the differential diagnosis of inhalational anthrax using electronic communication in a practice-based research network.
    Temte JL; Anderson AL
    Ann Fam Med; 2004; 2(5):434-7. PubMed ID: 15506577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003.
    Besselaar TG; Botha L; McAnerney JM; Schoub BD
    J Med Virol; 2004 May; 73(1):71-8. PubMed ID: 15042651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The primary care differential diagnosis of inhalational anthrax.
    Temte JL; Zinkel AR
    Ann Fam Med; 2004; 2(5):438-44. PubMed ID: 15506578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of influenza in the 1973 outbreak].
    Smagulov KZ; Bol'bot VI; Bigimbetova ShSh; Aleksandrov VS; Izimbergenova TT
    Klin Med (Mosk); 1974 Feb; 52(2):63-4. PubMed ID: 4466917
    [No Abstract]   [Full Text] [Related]  

  • 17. Sources of bioterrorism information among emergency physicians during the 2001 anthrax outbreak.
    M'ikanatha NM; Lautenbach E; Kunselman AR; Julian KG; Southwell BG; Allswede M; Rankin JT; Aber RC
    Biosecur Bioterror; 2003; 1(4):259-65. PubMed ID: 15040206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anthrax epidemic accompanying an epizootic outbreak in goats].
    Buşilă VT; Ionescu I; Popian R; Petrică L; Vilceanu M; Crişan I; Pintea L
    Microbiol Parazitol Epidemiol (Bucur); 1966; 11(2):139-45. PubMed ID: 6006585
    [No Abstract]   [Full Text] [Related]  

  • 19. Chinese curses, anthrax, and the risk of bioterrorism.
    Schultz CH
    Ann Emerg Med; 2004 Mar; 43(3):329-32. PubMed ID: 14985658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathology of anthrax sepsis according to materials of the infectious outbreak in 1979 in Sverdlovsk (microscopic changes)].
    Abramova AA; Grinberg LM
    Arkh Patol; 1993; 55(1):18-23. PubMed ID: 7980033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.